DSGN R&D Expenses

Design Therapeutics Inc · R&D Expenses

DSGN logo

DSGN R&D Expenses

Latest reported$58.78M
DSGN TTM R&D Expenses ($6.06M → $58.78M)
High-resolution chart · PNG

DSGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Design Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
58,781,000
58,131,000
59,129,000
57,861,000
55,148,000
49,775,000
44,056,000
42,911,000
44,292,000
50,991,000
57,063,000
60,306,000
61,353,000
55,584,000
48,613,000
41,695,000
35,930,000
29,662,000
24,778,000
20,149,000
13,524,000
9,558,000
6,060,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.